Notice: This company has been marked as potentially delisted and may not be actively trading. Depomed (DEPO) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Pfizer: Investor Activism Is Not The SolutionOctober 9, 2024 | seekingalpha.comNeuropathic Pain Market Demand to Hit USD 13.16 Billion by 2033 | Globally at 5.55% CAGRSeptember 5, 2024 | finance.yahoo.comVulvodynia Treatment Market Size and Growth Analysis | Future Trends Analysis and Revenue Status 2023-2030October 30, 2023 | finance.yahoo.comHorizon Pharma (HZNP) Stock Sinks After DepoMed Rejects Unsolicited $3 Billion BidAugust 29, 2023 | thestreet.comWhy DepoMed (DEPO) Stock Is Gaining TodayAugust 13, 2023 | thestreet.comSurge in Chronic Disorders Fuels Expansion of Global Tapentadol Market, Projected to Hit USD 5.32 Billion by 2028July 31, 2023 | finance.yahoo.comOpioid Litigants Get Boost From Senate ReportJuly 8, 2023 | thestreet.comChronic Fatigue Syndrome Therapeutics Drug Market Till 2030May 17, 2023 | marketwatch.comPain Management Market Size, Outlook, Trends, Share by 2030May 12, 2023 | marketwatch.comGlobal Neuropathy Pain Treatment Market [2023] | Industry Set to Expand with Strong 3.4% CAGR and Reach USD 10560 Million by 2030May 11, 2023 | marketwatch.comHow Turkey's opposition is taking the taboo out of the headscarf debateMay 10, 2023 | msn.comGlobal Gabapentin Market by Size, Scope 2023: with Development Status 2031April 29, 2023 | marketwatch.com2023-2030 Chronic Pain Management Drugs Market Size with Manufactures and Upcoming OpportunitiesApril 23, 2023 | marketwatch.comDepomed, Insys Shares Down After FDA Decision on Endo's Opana ERApril 17, 2023 | thestreet.comPeripheral Neuritis Treatment research report leads towards the developing of this industry with an estimated CAGR 11.1% during 2023-2030April 15, 2023 | marketwatch.comNeuropathy Pain Treatment Market Growth Prediction and Segment Insight 2023-2107April 13, 2023 | marketwatch.comNeuropathy Pain Treatment Market 2023 Size and Forecast to 2031April 5, 2023 | marketwatch.comVulvodynia Treatment Market: Overview of the Regional Outlook 2023-2030March 30, 2023 | marketwatch.comPain Management Market Size, Growth | Soaring Demand | 2023 - 2029March 14, 2023 | marketwatch.comPain Relief Medications Market Research Report 2023-2028 with Top Countries DataMarch 13, 2023 | marketwatch.comDiabetic Neuropathy Treatment Market 2023 Exploring New Challenges and Opportunities, Forecast to 2028February 21, 2023 | marketwatch.comControlled Release Drug Delivery Market 2023 Expected to Reach Significant Rate by 2029February 3, 2023 | marketwatch.comNeuropathy Pain Treatment Market Growth, Size, Share, Opportunities, Industry Analysis and Forecast 2023 To 2028January 29, 2023 | marketwatch.comCFO Says Depomed to Buy or Be SoldJanuary 23, 2023 | thestreet.comNeuropathic Pain Management Market Size, Share and Forecast 2028 with Top Countries DataJanuary 3, 2023 | marketwatch.comJ.D. Vance Cancels Fundraiser Planned by Doctor Mentioned in Opioid Lawsuit - NewsweekOctober 15, 2022 | newsweek.comPain Management Drugs Market is Growing Worldwide | 133 Report PagesOctober 12, 2022 | marketwatch.comNeuropathy Pain Treatment Market Size and Share Research 2022 Key Dynamics, Leading Companies, Business Developments and Demand Forecast 2030October 8, 2022 | marketwatch.comChronic Fatigue Syndrome Treatment Market Growing Demand and Trends 2022 to 2028 – Pfizer, Teva, MylanOctober 4, 2022 | marketwatch.comOpioid MDL Attys To Get 'Much More Aggressive' As Talks Lag - Law360September 22, 2022 | law360.comAssertio Holdings (ASRT) Looks Good To Rebound After Recent Price Plunge - Seeking AlphaSeptember 7, 2022 | seekingalpha.comREVOLUTION MEDICINES, INC. : Change in Directors or Principal Officers (form 8-K) - Marketscreener.comSeptember 1, 2022 | marketscreener.comRevolution Medicines Strengthens Senior Management Team with Promotions and a New Hire - Yahoo FinanceSeptember 1, 2022 | finance.yahoo.com(RVMD) – Revolution Medicines Strengthens Senior Management Team with Promotions and a New Hire - BenzingaSeptember 1, 2022 | benzinga.comRevolution Medicines Strengthens Senior Management Team with Promotions and a New Hire - GlobeNewswireSeptember 1, 2022 | globenewswire.comPain Management Therapeutics Market Size Share Volume Trends Demand Forecast Report 2022-2028August 20, 2022 | marketwatch.comVulvodynia Treatment Market : An Exclusive Study On Upcoming Trends And Growth Opportunities from 2022-2028 | 87 Pages ReportAugust 19, 2022 | marketwatch.comControlled Release Drug Delivery Market Worth USD 91.2 Billion by 2026June 10, 2022 | marketwatch.comAssertio Holdings, Inc. (ASRT) CEO Daniel Peisert on Q1 2022 Results - Earnings Call Transcript - Seeking AlphaMay 10, 2022 | seekingalpha.comLevi & Korsinsky, LLP Announces Proposed Settlement of the Depomed (nka Assertio Therapeutics) Securities LitigationApril 25, 2022 | markets.businessinsider.comLevi & Korsinsky, LLP Announces Proposed Settlement of the Depomed (nka Assertio Therapeutics) Securities Litigation - PR NewswireApril 25, 2022 | prnewswire.comGlobal Targeted Drug Delivery Market to Surpass US$ 22,704 Million by 2030, Says Coherent Market Insights (CMI) - Yahoo FinanceApril 22, 2022 | finance.yahoo.comDiaCarta Expands Board Leadership with Industry Veteran - PR NewswireApril 7, 2022 | prnewswire.comGlobal Pain Therapeutics Market to 2029 - Featuring Abbott Laboratories, AstraZeneca and GlaxoSmithKline - BenzingaMarch 28, 2022 | benzinga.comProtagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President and Chief Financial Officer - Yahoo FinanceMarch 28, 2022 | finance.yahoo.comProtagonist Therapeutics Appoints Asif Ali As Executive Vice President And CFO - NasdaqMarch 28, 2022 | nasdaq.comMeet NJ Federal Court's New Magistrate Judge - Law360March 23, 2022 | law360.comJohnson & Johnson: Your 101 Guide To Litigation Protection - Bankruptcy - Seeking AlphaMarch 7, 2022 | seekingalpha.comKetanji Brown Jackson No 'Rubber Stamp' For Gov't Agencies - Law360March 3, 2022 | law360.comThe Jackson Ruling That Reverberates In Drug Pricing Debate - Law360March 1, 2022 | law360.com Get Depomed News Delivered to You Automatically Sign up to receive the latest news and ratings for DEPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! DEPO Media Mentions By Week DEPO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DEPO News Sentiment▼0.000.35▲Average Medical News Sentiment DEPO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DEPO Articles This Week▼00▲DEPO Articles Average Week Get Depomed News Delivered to You Automatically Sign up to receive the latest news and ratings for DEPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News JNJ News ABBV News MRK News PFE News BMY News ZTS News RPRX News JAZZ News CORT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DEPO) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Depomed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Depomed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
